Nexipraz Iv 40 mg Powder for solution for injection & infusion
PDF Leaflet Revision Date: 02 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastro-oesophageal reflux disease and maintenance of haemostasis in bleeding ulcers.
Dosage (summary)
40 mg IV once daily for GORD; 80 mg bolus for bleeding ulcers.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Caution in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Clopidogrel
- Warfarin
- Tacrolimus
Contraindications
- Hypersensitivity to esomeprazole
- Concomitant use with nelfinavir and atazanavir
Common side effects
- Headache
- Dizziness
- Nausea
- Abdominal pain
Counselling Points
- Monitor for signs of hypomagnesaemia
- Avoid in children
- Caution when driving or operating machinery
Serious warnings
- Risk of gastrointestinal infections
- Hypomagnesaemia
- Risk of fracture
Important Disclaimer
The Nexipraz Iv 40 mg Powder for solution for injection & infusion professional information leaflet below is the property of Pharmaco Distribution and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
